IGC Earnings

Quarterly EPS
$-0.09
Q3 2024
$-0.04
Q4 2024
$-0.02
Q3 2025
$-0.02
Q1 2025
$-0.02
Q4 2025
$-0.02
Q2 2025
$-0.02
Q1 2026
$-0.03
Q2 2026
Latest Revenue265.0K
Latest Net Income-2936000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.03265.0K-2936000-19.7%-50.0%
Q1 2026-$0.02317.0K-2402000+23.3%+0.0%
Q2 2025-$0.02328.0K-1599000+11.2%+50.0%
Q4 2025-$0.02330.0K-1197000+61.8%+77.8%
Q1 2025-$0.02330.0K-1198000+13.4%+60.0%
Q3 2025-$0.02257.0K-1829000-53.7%+50.0%
Q4 2024-$0.04295.0K-2885000+77.7%+50.0%
Q3 2024-$0.09204.0K-5589000-38.6%-125.0%
Q2 2024-$0.05291.0K-2451000
Q1 2024-$0.04555.0K-2075000
Q4 2023-$0.08166.0K-4030000
Q3 2023-$0.04332.0K-2249000
IGC Pharma (IGC) — Earnings